These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease. Khadawardi H; Mura M Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639 [TBL] [Abstract][Full Text] [Related]
7. Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review. Kašiković Lečić S; Javorac J; Živanović D; Lovrenski A; Tegeltija D; Zvekić Svorcan J; Maksimović J Ups J Med Sci; 2022; 127():. PubMed ID: 35910492 [TBL] [Abstract][Full Text] [Related]
11. Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D. Rautajoki T; Lehto JT; Sutinen E; Bergman P; Sintonen H; Rajala K; Mäkelä K; Hollmen M; Saarto T; Myllärniemi M J Palliat Med; 2023 Oct; 26(10):1357-1364. PubMed ID: 37366772 [No Abstract] [Full Text] [Related]
12. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis. Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284 [TBL] [Abstract][Full Text] [Related]
13. Evaluation and management of Idiopathic Pulmonary Fibrosis. Kishaba T Respir Investig; 2019 Jul; 57(4):300-311. PubMed ID: 30853366 [TBL] [Abstract][Full Text] [Related]
14. [The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis]. Vainshelboim B; Kramer MR Harefuah; 2012 Apr; 151(4):220-4, 253. PubMed ID: 22616150 [TBL] [Abstract][Full Text] [Related]
15. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079 [TBL] [Abstract][Full Text] [Related]
16. Validation of a Novel Clinical Dyspnea Scale - A Retrospective Pilot Study. Kalluri M; Cui Y; Wang T; Bakal JA Am J Hosp Palliat Care; 2024 Mar; 41(3):253-261. PubMed ID: 36977656 [No Abstract] [Full Text] [Related]
17. Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function. Zhang X; Li W; Li C; Zhang J; Su Z BMC Pulm Med; 2021 Apr; 21(1):122. PubMed ID: 33858421 [TBL] [Abstract][Full Text] [Related]
18. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients. Feng H; Zhao Y; Li Z; Kang J Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705 [TBL] [Abstract][Full Text] [Related]
19. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592 [TBL] [Abstract][Full Text] [Related]
20. Patient Activation for Self-Management in Patients with Idiopathic Pulmonary Fibrosis or Sarcoidosis. Bloem AEM; Mostard RLM; Stoot N; Custers JWH; Vooijs M; Janssen DJA; van 't Hul AJ; Spruit MA Respiration; 2022; 101(1):76-83. PubMed ID: 34515234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]